SLFN11 has been shown to predict response to DDA in different cancer models (1, 3–5, 54, 56), but to our knowledge, we describe here for the first time that SLFN11 has more predictive power when its expression in the stromal noncancer compartment is taken into account. This evidence concerns the gene SLFN11 and cancer.